Prof. A. C. Matin

Department of Microbiology and Immunology

Stanford University School of Medicine, USA

Professor

Email: A.Matin@stanford.edu

Qualifications

1969 Ph.D., University of California, Los Angeles, Microbiology

Publications (selected)

1. Thorne, S, Barak, Y., Liang, W., Bachmann, M.H., Rao, J, Contag, C., and Matin, A. CNOB/ChrR6. 2009. A new prodrug enzyme cancer chemotherapy. Molecular Cancer Therapeutics 8: 333-341.
2. Benoit, M.R., D. Mayer, Y. Barak, I.Y. Chen, W. Hu,  Z. Cheng, S.X. Wang, D.M. Spielman, S.S. Gambhir, and A Matin. 2009. Visualizing implanted tumors in mice with MRI using magnetotactic bacteria. Clinical Cancer Research 15 (16): 5170 – 5177.
3. Lynch, S., L. Dixon, E.L. Brodie, M. Keyhan, P. Hu, D.F. Ackerley, G.L. Andersen and A. Matin. 2007. Role of the rapA gene in controlling antibiotic resistance in urpopathogenic Escherichia coli. Antimicrobial Agents and Chemotherapy, 51: 3650-3658.
4. Lynch, S.V., L. Dixon, M.R. Benoit, E.L. Brodie, M. Keyhan, P. Hu, D.F. Ackerley, G.L. Andersen and A. Matin. 2007. Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrobial Agents and Chemotherapy 51: 3650 – 3658.
5. Barak, Y., F. Schreiber, S.H. Thorne, C.H. Contag, D. deBeer, and A Matin. 2010. Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing. BMC Cancer 10: 146-152.
6. Benoit, MR, Conant, C, Ionescu-Zanetti, C, Schwartz, M, and Matin, A. New device for high throughput viability screening of flow-bioflims. 2010. Applied and Environmental Microbiology 76 (13): 4136-4142.
7. Ackerley, D.F., Y. Barak, S.V. Lynch, J. Curtin, and A. Matin. 2006. Effect of chromate stress on Escherichia coli K12. Journal of Bacteriology 188: 3371-3381.
8. Lynch, S.V., K. Mukundakrishnan, P. Ayyaswami, and A. Matin. 2006. Escherichia coli biofilms formed under low shear simulated microgravity in a ground-based system. Applied & Environmental Microbiology 72: 7701-7710.
9. Barak, Y., D. F. Ackerley, C. J. Dodge, B. Lal, A. Cheng, A. J. Francis, and A. Matin. 2006. Analysis of novel soluble Cr(VI) and U(VI) reductases and generation of improved enzymes using directed evolution. Applied and Environmental Microbiology, 72: 7074-7082.
10. Barak, Y., S.H. Thorne, D. F. Ackerley, S.V. Lynch, C.H. Contag, and A. Matin. 2006. New enzyme for reductive cancer chemotherapy (YieF) and its improvement by directed evolution. Molecular Cancer Therapeutics 5: 97-103.
11. Gonzalez, C.F., D.F. Ackerley, S.V. Lynch, and A. Matin. 2005. ChrR, a soluble quinone reductase of Pseudomonas putida that defends against H2O2. The Journal of Biological Chemistry. 280: 22590-22595.
12. Ackerley, D.F., C.F. Gonzalez, C.H. Park, R. Blake II, M. Keyhan, and A. Matin. 2004. Chromate reducing properties of soluble flavoproteins from Pseudomonas putida and Escherichia coli. Applied & Environmental Microbiology, 70: 873-882.
13. Ackerley, D.F., C.F. Gonzalez, C.H. Park, R. Blake II, M. Keyhan, and A. Matin. 2004. Mechanism of chromate reduction by the Escherichia coli protein, NfsA, and the role of different chromate reductases in minimizing oxidative stress during chromate reduction. Environmental Microbiology, 6: 851-860.
14. Lynch, S., E.L. Brodie, and A. Matin. 2004.Role and regulation ofss in low shear microgravity-conferred general resistance in Escherichia coli. Journal of Bacteriology 186: 8207-8212.

Profile Details

http://www.stanford.edu/~amatin/MatinLabHomePage/MatinLabHome-Page.htm